BELVIN MARCIA Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$54,494.77

Insider Activity of BELVIN MARCIA

According to the SEC Form 4 filings, BELVIN MARCIA, being in a position of

  1. SVP, Chief Scientific Officer at CytomX Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31492 shares for $202,273,
    over all time since 2023-09-22, has bought 0 shares, and sold 90060 shares for $294,102.

Biography of BELVIN MARCIA

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$202,2731100

Comparison of Insiders on Amount of Buys and Sells

2026-03-17SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
31,492
0.0219%
$6.42$202,273-37.25%
2025-06-16SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
13,884
0.0096%
$2.69$37,334+54.88%
2025-03-18SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
19,512
0.0242%
$0.60$11,688+338.96%
2024-08-20SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,181
0.0053%
$1.23$5,139-10.08%
2024-03-19SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
12,795
0.0181%
$2.09$26,684-45.64%
2023-12-20SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,077
0.0063%
$1.38$5,628+5.6%
2023-09-22SaleCytomX Therapeutics, Inc.
CTMX
SVP, Chief Scientific Officer
4,119
0.0063%
$1.30$5,356+12.5%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.